Ozempic predecessor suggests potential for GLP-1 drugs in ... - CNN
Jul 30, 2024 · The study, of 204 people with Alzheimer’s disease in the United Kingdom, found that those taking the diabetes drug liraglutide – an earlier medication in Ozempic’s class, …
Weight loss drug liraglutide shows real promise for younger
Sep 10, 2024 · CNN — Children who used the weight loss drug liraglutide in a late-stage trial lost significantly more weight than children who got a placebo, according to a new study. Doctors …
Teva Announces Launch of Authorized Generic of Victoza® (liraglutide …
Jun 24, 2024 · Teva Pharmaceuticals, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), announced today the launch of an authorized generic of Victoza ®1 …
Victoza: Generic GLP-1 Drug Similar to Ozempic Now Available - Healthline
Jul 3, 2024 · Teva Pharmaceuticals announced the launch of a generic form of Victoza (liraglutide), the first-ever generic GLP-1 drug to be made available in the United States.
GLP-1 Drug Liraglutide May Protect Against Dementia
PHILADELPHIA, July 30, 2024 — A glucagon-like peptide-1 (GLP-1) drug appears to slow cognitive decline by protecting the brain, according to Phase 2b clinical trial data reported …
FDA approves weight management drug for patients aged 12 …
The U.S. Food and Drug Administration has approved Saxenda (liraglutide) for chronic weight management among patients aged 12 and older who are obese.
Novo Nordisk GLP-1 liraglutide may slow Alzheimer's progression
Jul 30, 2024 · An older, once-daily drug for diabetes and obesity from Novo Nordisk called liraglutide may slow the progression of Alzheimer’s disease by protecting patients’ brains, …
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
Jul 28, 2016 · The cardiovascular effect of liraglutide, a glucagon-like peptide 1 analogue, when added to standard care in patients with type 2 diabetes, remains unknown. In this double-blind …
A Randomized, Controlled Trial of Liraglutide for Adolescents …
Mar 31, 2020 · Liraglutide, a glucagon-like peptide 1 (GLP-1) analogue, increases the postprandial insulin level in a glucose-dependent manner, reduces glucagon secretion, delays …
Liraglutide - latest research news and features - Medical Xpress
For adults with obesity, without diabetes, combining exercise with the glucagon-like peptide-1 receptor agonist (GLP-1 RA), liraglutide, is effective for weight loss, while preserving bone …